Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Organisation › Details

HBM Healthcare Investments AG (SIX: HBMN)

HBM Healthcare Investments invests in the healthcare sector. The company holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided in their strategic direction. This is what makes HBM Healthcare Investments an interesting alternative to investments in big pharma and biotechnology companies. HBM Healthcare Investments, with funds under management of more than EUR 1 bn, has an international shareholder base and is listed on SIX Swiss Exchange (HBMN). *


Period Start 2012-12-19 existent
  Group HBM (Group)
  Predecessor HBM BioVentures AG
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Person Person Wicki, Andreas (HBM Healthcare Investments 201402 CEO)
  Street 1 Bundesplatz
  City 6300 Zug
  Tel +41-41-768-1108
    Address record changed: 2018-07-24
Basic data Employees n. a.
  Currency USD
  Annual sales 1,000,000,000 (funds, managed (2018) 2018-11-26)
    * Document for �About Section�: Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug.
Record changed: 2020-10-10


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for HBM (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top